Please enable JavaScript to continue using this application.

Compare $ALDX vs $CNTB | Chartloom

Compare

$ALDX vs $CNTB

Aldeyra Therapeutics Inc · Connect Biopharma Holdings Ltd

ALDX

Aldeyra Therapeutics Inc

CNTB

Connect Biopharma Holdings Ltd

Compare $ALDX vs $CNTB

Comparing Aldeyra Therapeutics Inc and Connect Biopharma Holdings Ltd

ALDXAldeyra Therapeutics Inc

CNTBConnect Biopharma Holdings Ltd

ALDXAldeyra Therapeutics Inc

Market cap

$55M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.4%

52W performance

-83.7%

FCF yield

-39.9%

CNTBConnect Biopharma Holdings Ltd

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.55x

Rev growth (TTM)

—

YTD performance

-65.5%

52W performance

-52.2%

FCF yield

-125.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALDX

CNTB

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

CNTB

Connect Biopharma Holdings Ltd

Market Cap

ALDX$55M

CNTB$48M

Enterprise Value

ALDX$10M

CNTB$21M

Price

ALDX$0.92

CNTB$0.87

P/E Ratio

ALDXN/A

CNTBN/A

P/S Ratio

ALDX0.00x

CNTB16.42x

EV/Sales

ALDX0.00x

CNTB7.27x

EV/EBITDA

ALDX0.00x

CNTB0.00x

P/B Ratio

ALDX1.86x

CNTB2.17x

P/FCF Ratio

ALDXN/A

CNTBN/A

EV/FCF

ALDX-0.46x

CNTB-0.35x

PEG Ratio

ALDXN/A

CNTBN/A

Forward P/E (NTM)

ALDXN/A

CNTBN/A

Forward P/S (NTM)

ALDXN/A

CNTB5.55x

Revenue (TTM)

ALDX$0

CNTB$3M

Revenue Growth (YoY)

ALDXN/A

CNTBN/A

Forward Rev Growth

ALDX298.2%

CNTB98.8%

Gross Margin (TTM)

ALDX0.0%

CNTB0.0%

Operating Margin (TTM)

ALDX0.0%

CNTB0.0%

EBITDA Margin (TTM)

ALDX0.0%

CNTB-2361.3%

Net Margin (TTM)

ALDX0.0%

CNTB-2336.3%

FCF Margin (TTM)

ALDXN/A

CNTB-2053.3%

Net Income (TTM)

ALDX$-23M

CNTB$-69M

FCF (TTM)

ALDX$-22M

CNTB$-61M

EPS (TTM)

ALDX-$0.38

CNTB-$1.24

ROE (TTM)

ALDX-5314.0%

CNTB-16541.0%

ROA (TTM)

ALDX-3494.0%

CNTB-12158.0%

ROIC (TTM)

ALDX-4205.0%

CNTB-16541.0%

Cash

ALDX$45M

CNTB$27M

Debt

ALDX$0

CNTB$0

Net Cash/Debt

ALDX$45M

CNTB$27M

Current Ratio (TTM)

ALDX4.91x

CNTB2.37x

Quick Ratio (TTM)

ALDX4.74x

CNTB2.11x

Debt/Equity (TTM)

ALDX0.34x

CNTB0.00x

Debt/Assets (TTM)

ALDX0.0%

CNTB0.0%

Interest Coverage (TTM)

ALDXN/A

CNTBN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

CNTB0.00x

Beta

ALDX1.21

CNTB-0.07

52W Performance

ALDX-83.7%

CNTB-52.2%

YTD Performance

ALDX-80.4%

CNTB-65.5%

% from 52W High

ALDX-84.5%

CNTB-77.2%

% from 52W Low

ALDX6.3%

CNTB2.3%

Asset Turnover (TTM)

ALDX0.00x

CNTB0.05x

FCF Yield (TTM)

ALDX-39.9%

CNTB-125.1%

Earnings Yield (TTM)

ALDX-41.7%

CNTB-142.3%

Dividend Yield (TTM)

ALDXN/A

CNTBN/A

Rule of 40

ALDX0.0

CNTB-2,053.3

EV/GP/RG

ALDXN/A

CNTBN/A

Ticker research

View ALDX research View CNTB research

Metric	ALDX Aldeyra Therapeutics Inc	CNTB Connect Biopharma Holdings Ltd
Market & Valuation
Market Cap	$55M	$48M
Enterprise Value	$10M	$21M
Price	$0.92	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.42x
EV/Sales	0.00x	7.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	2.17x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-0.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.55x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	98.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2361.3%
Net Margin (TTM)	0.0%	-2336.3%
FCF Margin (TTM)	N/A	-2053.3%
Net Income (TTM)	$-23M	$-69M
FCF (TTM)	$-22M	$-61M
EPS (TTM)	-$0.38	-$1.24
ROE (TTM)	-5314.0%	-16541.0%
ROA (TTM)	-3494.0%	-12158.0%
ROIC (TTM)	-4205.0%	-16541.0%
Financial Health
Cash	$45M	$27M
Debt	$0	$0
Net Cash/Debt	$45M	$27M
Current Ratio (TTM)	4.91x	2.37x
Quick Ratio (TTM)	4.74x	2.11x
Debt/Equity (TTM)	0.34x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	-0.07
52W Performance	-83.7%	-52.2%
YTD Performance	-80.4%	-65.5%
% from 52W High	-84.5%	-77.2%
% from 52W Low	6.3%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-39.9%	-125.1%
Earnings Yield (TTM)	-41.7%	-142.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,053.3
EV/GP/RG	N/A	N/A
Ticker research	View ALDX research	View CNTB research

Valuation

P/S Ratio

ALDX

0.00x

CNTB

16.42x

EV/FCF

ALDX

-0.46x

CNTB

-0.35x

Growth & revenue

Forward Revenue Growth

ALDX

298.2%

CNTB

98.8%

Profitability & performance

Gross Margin

ALDX

0.0%

CNTB

0.0%

ROE

ALDX

-5314.0%

CNTB

-16541.0%

FCF Yield %

ALDX

-39.9%

CNTB

-125.1%

52-Week Performance

CNTB

-52.2%

ALDX

-83.7%

Detailed metrics comparison

ALDX

Aldeyra Therapeutics Inc

CNTB

Connect Biopharma Holdings Ltd

Market Cap

ALDX$55M

CNTB$48M

Enterprise Value

ALDX$10M

CNTB$21M

Price

ALDX$0.92

CNTB$0.87

P/E Ratio

ALDXN/A

CNTBN/A

P/S Ratio

ALDX0.00x

CNTB16.42x

EV/Sales

ALDX0.00x

CNTB7.27x

EV/EBITDA

ALDX0.00x

CNTB0.00x

P/B Ratio

ALDX1.86x

CNTB2.17x

P/FCF Ratio

ALDXN/A

CNTBN/A

EV/FCF

ALDX-0.46x

CNTB-0.35x

PEG Ratio

ALDXN/A

CNTBN/A

Forward P/E (NTM)

ALDXN/A

CNTBN/A

Forward P/S (NTM)

ALDXN/A

CNTB5.55x

Revenue (TTM)

ALDX$0

CNTB$3M

Revenue Growth (YoY)

ALDXN/A

CNTBN/A

Forward Rev Growth

ALDX298.2%

CNTB98.8%

Gross Margin (TTM)

ALDX0.0%

CNTB0.0%

Operating Margin (TTM)

ALDX0.0%

CNTB0.0%

EBITDA Margin (TTM)

ALDX0.0%

CNTB-2361.3%

Net Margin (TTM)

ALDX0.0%

CNTB-2336.3%

FCF Margin (TTM)

ALDXN/A

CNTB-2053.3%

Net Income (TTM)

ALDX$-23M

CNTB$-69M

FCF (TTM)

ALDX$-22M

CNTB$-61M

EPS (TTM)

ALDX-$0.38

CNTB-$1.24

ROE (TTM)

ALDX-5314.0%

CNTB-16541.0%

ROA (TTM)

ALDX-3494.0%

CNTB-12158.0%

ROIC (TTM)

ALDX-4205.0%

CNTB-16541.0%

Cash

ALDX$45M

CNTB$27M

Debt

ALDX$0

CNTB$0

Net Cash/Debt

ALDX$45M

CNTB$27M

Current Ratio (TTM)

ALDX4.91x

CNTB2.37x

Quick Ratio (TTM)

ALDX4.74x

CNTB2.11x

Debt/Equity (TTM)

ALDX0.34x

CNTB0.00x

Debt/Assets (TTM)

ALDX0.0%

CNTB0.0%

Interest Coverage (TTM)

ALDXN/A

CNTBN/A

Net Debt/EBITDA (TTM)

ALDX0.00x

CNTB0.00x

Beta

ALDX1.21

CNTB-0.07

52W Performance

ALDX-83.7%

CNTB-52.2%

YTD Performance

ALDX-80.4%

CNTB-65.5%

% from 52W High

ALDX-84.5%

CNTB-77.2%

% from 52W Low

ALDX6.3%

CNTB2.3%

Asset Turnover (TTM)

ALDX0.00x

CNTB0.05x

FCF Yield (TTM)

ALDX-39.9%

CNTB-125.1%

Earnings Yield (TTM)

ALDX-41.7%

CNTB-142.3%

Dividend Yield (TTM)

ALDXN/A

CNTBN/A

Rule of 40

ALDX0.0

CNTB-2,053.3

EV/GP/RG

ALDXN/A

CNTBN/A

Ticker research

View ALDX research View CNTB research

Metric	ALDX Aldeyra Therapeutics Inc	CNTB Connect Biopharma Holdings Ltd
Market & Valuation
Market Cap	$55M	$48M
Enterprise Value	$10M	$21M
Price	$0.92	$0.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.42x
EV/Sales	0.00x	7.27x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.86x	2.17x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-0.35x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.55x
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	298.2%	98.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2361.3%
Net Margin (TTM)	0.0%	-2336.3%
FCF Margin (TTM)	N/A	-2053.3%
Net Income (TTM)	$-23M	$-69M
FCF (TTM)	$-22M	$-61M
EPS (TTM)	-$0.38	-$1.24
ROE (TTM)	-5314.0%	-16541.0%
ROA (TTM)	-3494.0%	-12158.0%
ROIC (TTM)	-4205.0%	-16541.0%
Financial Health
Cash	$45M	$27M
Debt	$0	$0
Net Cash/Debt	$45M	$27M
Current Ratio (TTM)	4.91x	2.37x
Quick Ratio (TTM)	4.74x	2.11x
Debt/Equity (TTM)	0.34x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	-0.07
52W Performance	-83.7%	-52.2%
YTD Performance	-80.4%	-65.5%
% from 52W High	-84.5%	-77.2%
% from 52W Low	6.3%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-39.9%	-125.1%
Earnings Yield (TTM)	-41.7%	-142.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-2,053.3
EV/GP/RG	N/A	N/A
Ticker research	View ALDX research	View CNTB research